KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortization of GoodwillCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Change in Receivables (2016 - 2025)

Cvs Health's Change in Receivables history spans 17 years, with the latest figure at -$4.0 billion for Q4 2025.

  • For the quarter ending Q4 2025, Change in Receivables fell 101.13% year-over-year to -$4.0 billion, compared with a TTM value of $3.5 billion through Dec 2025, down 99.02%, and an annual FY2025 reading of $3.5 billion, down 99.02% over the prior year.
  • Change in Receivables for Q4 2025 was -$4.0 billion at Cvs Health, down from $3.4 billion in the prior quarter.
  • The five-year high for Change in Receivables was $357.0 billion in Q4 2024, with the low at -$87.8 billion in Q2 2024.
  • Average Change in Receivables over 5 years is $35.6 billion, with a median of $1.5 billion recorded in 2021.
  • Year-over-year, Change in Receivables plummeted 197.92% in 2021 and then soared 24180.0% in 2023.
  • Tracing CVS's Change in Receivables over 5 years: stood at -$801.0 million in 2021, then surged by 220.1% to $962.0 million in 2022, then skyrocketed by 8752.81% to $85.2 billion in 2023, then skyrocketed by 319.2% to $357.0 billion in 2024, then crashed by 101.13% to -$4.0 billion in 2025.
  • Per Business Quant, the three most recent readings for CVS's Change in Receivables are -$4.0 billion (Q4 2025), $3.4 billion (Q3 2025), and -$86.7 billion (Q2 2025).